Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX vs XELOX in Stage III Colorectal Cancer
NCT03448549Phase 3Unknown
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in colorectal cancer (CRC), sponsored by Peking University Cancer Hospital & Institute. Status: unknown.
02
Drugs
tegafur
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03448549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448549.